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Abstract
Background: The human amniotic membrane (HAM) is a suitable and effective scaffold
for cell culture and delivery, and adipose-derived stem cells (ADSCs) are an important
source of stem cells for transplantation and chondrogenic differentiation.
Objective: To assess the practicability of a cryopreserved HAM as a scaffold in cell
proliferation and differentiation in vitro.
Materials and Methods: In this experimental study, adipose tissue samples were
harvested from the inguinal region of male patients aged 15-30 years. Flow cytometry
was used to identify CD31, CD45, CD90, and CD105 markers in adipose stem
cells. HAM was harvested from donor placenta after cesarean section, washed,
trypsin-based decellularized trypsinized decellularized, and used as a scaffold via
three methods: 1) ADSCs were differentiated into chondrocytes on cell culture flasks
(monolayermethod), and after 14 days of culture, the cells were transferred and cultured
on both sides of the HAM; 2) ADSCs were cultured and differentiated directly on both
sides of the HAM for 14 days (scaffold-mediated differentiation); and 3) chondrocytes
were differentiated with micromass culture for 14 days, transferred on HAM, and tissue
slides were histologically analyzed qualitatively.
Results: Flow cytometry confirmed the presence of mesenchymal stem cells.
Histological findings revealed that the cells adhered and grew well on the stromal layer
of HAM. Among the threemethods, scaffold-mediated differentiation of ADSCs showed
the best results.
Conclusion: ADSCs have excellent attachment, viability, and differentiation capacity in
the stromal side of HAM. Additionally, the direct culture and differentiation of ADSCs
on HAM is more suitable than the culture of differentiated cells on HAM.
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1. Introduction
Approximately 22.7% of the population
of the United States has osteoarthritis and
approximately 9.8% have arthritis-attributable
activity limitation; these figures are expected
to continuously increase with age (1). Due to
the low repair capacity in articular cartilage
and the lack of successful techniques for its
repair, arthroplasty remains the main treatment
for severe osteoarthritis. Its outcomes include
pain reduction and mobility improvement for
performance of activities of daily living (2).
Furthermore, the most common reasons for
total joint replacement are aseptic and septic
loosening, dislocation, periprosthetic fractures,
pain, wear, and technical errors, which require
subsequent surgeries (3). Due to high surgical
cost and limited effectiveness, the construction
of a tissue-engineered cartilage may result in
remarkable improvement in ADL performance
of patients with osteoarthritis. The articular
cartilage is considered a good source of
endogenous chondrocytes, but the use of
this type of cells is associated with further
damage to the articular cartilage (4). Tissue
engineering is a prospective approach suitable
for the reconstruction of damaged cartilage (5).
In cartilage tissue engineering involves a scaffold.
seed cells, and growth factors (6). Owing to
the limited use of autologous cells, researchers
use allogeneic stem cells to prepare functional
researchers use allogeneic stem cells for using
in tissue engineering applications. In addition,
because of the possible immunological rejection
of allogeneic cells, the use of mesenchymal
stem cells (MSCs) is important (7). Furthermore,
the use of a decellularized extracellular matrix
(ECM) as a scaffold to construct tissue-engineered
cartilage has drawn considerable attention in
recent years (8). Human adipose-derived stem
cells (ADSCs), which can be easily obtained
from subcutaneous fat tissues by liposuction or
arthroscopy, are a suitable source of multipotent
MSCs. In vitro expansion of these cells has
shown that these cells remain undifferentiated
and have no change in telomerase activity
even after the ninth passage (9). Moreover,
the chondrogenic differentiation capacity of
ADSCs has been demonstrated in several
studies (10). These characteristics as well as high
proliferation potential, secretion of angiogenic
factors and healing-associated growth factors,
and easy culture and differentiation into other
cell lines make ADSCs a promising cell source
for tissue engineering and cell therapy (11). The
human amniotic membrane (HAM) is a thin
fetal tissue with favorable characteristics such
as affordability, ease of availability, as well as
antibacterial and anti-inflammatory properties.
In addition, the presence of collagen types
I, III, and IV; laminin; fibronectin; and various
growth factors makes it a highly promising
scaffold for cartilage tissue engineering (11).
Cellular and acellular HAMs have been widely
used clinically in regenerative medicine and/or
experimental studies (12). In previous studies,
fibroblasts (13), keratinocytes (14), epithelial
cells (15), and chondrocytes (16) were cultured
on amniotic membranes. In this study, for
the first time, we cultured and differentiated
ADSCs on HAM as a scaffold via three different
methods.
The aim of this study was to investigate whether
HAM could support the proliferation, attachment,
and chondrogenic differentiation of ADSCs using
histological evaluation.
2. Materials and Methods
2.1. Stem cell isolation and culture
In this cross-sectional study, adipose tissue
samples were obtained from the inguinal
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region of 15 male patients (age: 15-30 yr)
who were referred for hernia repair. These
samples were transferred to the cell culture
lab in a Falcon tube containing PBS with 1%
Pen/Strep. Explant culture was used to isolate
ADSCs. In brief, samples were cut into small
pieces (1-2 mm2) after washing twice with
sterile PBS containing 1% Pen/Strep to remove
blood and extra tissues. The tissue pieces
were cultured in Petri dishes and were left
undisturbed to allow the exit of cells from the
margins of explants. After the cells grew out of
the explants, the tissue pieces were removed
and cells were passaged when they reached
approximately 70% confluency. Third- or fourth-
passage ADSCs were used for chondrogenic
differentiation.
2.2. Flow cytometry
Flow cytometry was performed to confirm and
identify the surface markers of MSCs. To this
end, two specific surface markers of stromal
MSCs (CD105 and CD90) and two specific
markers of hematopoietic MSCs (CD31 and
CD45) were studied. In brief, 2 × 105 fourth-
passage cells were transferred to each control
and test Falcon tube after counting using a
hemocytometer. Then, they were centrifuged
for 5 min at 2500 rpm and the supernatant
was drained. Cell deposition was solved in 3%
BSA and incubated on ice for 30 min. Then,
CD90, CD45, CD31, and CD105 conjugated with
phycoerythrin (PE) antibodies were added to
the test tubes. The samples were incubated
for 1 h in dark at room temperature. Next, PBS
was added to the tubes and centrifuged for 1
min at 2500 rpm. The supernatant was drained,
and the labeled cell masses were dissolved in
PBS and analyzed by flow cytometry (Becton
Dickinson).
2.3. HAM preparation
HAM was immediately isolated from the
donor placenta using sterile scissors. Samples
were washed with normal saline solution to
remove blood; then, the samples were placed
in a Falcon tube containing sterile PBS with
1% Pen/Strep and quickly transferred to the
cell culture room of the anatomical laboratory
(Mazandaran University of Medical Sciences, Iran).
Next, under a laminar flow hood, the samples
were washed twice with sterile PBS containing 1%
Pen/Strep. For acellular HAM, trypsinization and
freezing/defreezing (3 times) were additionally
performed. Finally, HAM was transferred to a
Falcon tube containing sterile PBS and stored at
−18°C until use.
2.4. Cell culture and chondrogenic
differentiation usingHAMas a scaffold
Culture and differentiation of ADSCs using HAM
as a scaffold was performed using three methods:
• In the first method, 2.5 × 105 fourth-passage
ADSCs were first transferred to a 6-well culture
plate. A chondrogenic differentiation medium
(Invitrogen) was added and changed every 2 days.
After 14 days, chondrogenic differentiated ADSCs
were mechanically detached from the bottom of
the wells with a cell scraper and transferred onto
HAM.
• In the second method, HAM was loaded onto
the bottom of a 6-well culture plate. Then, 2.5 × 105
ADSCs were transferred to the center of HAM and
a chondrogenic differentiation medium was added,
which was changed every 2 days for 14 days.
• Micromass culture was used as the third
method. After trypsinization and centrifugation,
cells were resuspended in a small amount of
chondrogenic differentiation medium to make a
high-density cell solution containing 2.5 × 105
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cells/25 𝜇L droplet. A 25 𝜇L droplet was carefully
placed at the center of every well of a 24-
well culture plate. After 2-hr incubation, the
chondrogenic differentiationmediumwas added to
each well. The medium was changed every 3 days
for a total of 2 wk.
DMEMcontaining 10%FBS and 1%Pen/Strepwas
used for the control group in all methods.
To ensure adherence of HAM to the bottom
of wells and to culture cells, HAM was cut into
square pieces and fitted to the bottom of 6-
well plates. Samples were transferred into the
wells from both stromal and epithelial stromal and
epithelial sides of HAM (Figure 1A). These pieces
of HAM were incubated with 500 𝜆 FBS for 1 hr
before using them for homing and differentiation of
the cells.
2.5. Histological assessment
At the end of the culture and differentiation
periods, HAM samples containing ADSCs and
chondrogenic cells were fixed with 10% formalin for
24 hr. HAM samples containing chondrogenic cells
and ADSCs were placed on filter paper and fixed
using office pins (Figure 1B). The samples were
dehydrated in the graded alcohols, embedded in
paraffin, and stained sections and 5 micro meter
thick sections stained by hematoxylin and eosin. All
slides were examined by a histologist blindly under
an optical microscope (Nikon).
Figure 1. A) Human amniotic membrane attached to the bottom of a 6-well culture plate. B) Placing the sample on a filter paper
using office pins for processing and embedding in paraffin.
2.6. Ethical consideration
The instructions of the Ethics Committee of
Mazandaran University of Medical Sciences
were followed (IR.MAZUMS.REC.1393.1402),
and informed consent was obtained from the
patients admitted to Imam Khomeini Hospital in
Sari.
3. Results
3.1. Morphology of isolated cells
Heterogeneous adherent cells were observed
7 days after explanted adipose tissue fragments
were added to the flasks. This heterogeneous
cell population comprised circulating blood
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cells, fibroblasts, pericytes, endothelial cells,
and adipocyte progenitors (ADSCs). At this time,
the adipose tissue fragments were removed
from the flasks and the cells became confluent
on day 11 (Figure 2). After trypsinization and
subculture, the isolated ADSCs formed a
homogenous population of adherent fibroblast-like
cells.
3.2. Flow cytometry
The analysis of MSC CD markers by flow
cytometry showed that fourth-passage ADSCs
expressed an average of 78.3% CD105 (Figure
3A) and 94.9% CD90 (Figure 3B), which are
prominent MSC markers. However, <2% of these
cells expressed CD45 (Figure 3C) and CD31 (Figure
3D).
3.3. Histological findings
As the first approach in this study, ADSCs
were cultured on the epithelial and stromal
sides of HAM. As shown in Figure 4A, ADSCs
were seen separated from the epithelial side,
but in Figure 4B, the cells were seen to be
attached and proliferated. Additionally, some
ADSCs had integrated into the stromal layer of
HAM.
The next approach was to compare culturing
and differentiating ADSCs directly and indirectly
on HAM. In the first method, ADSCs were
cultured and differentiated appropriately on the
stromal side of HAM, and a proper thickness of
chondrogenic cells was seen. However, in the
control group, good proliferation was observed that
was comparable to that in the differentiation group;
and also, ADSCs integrated more into HAM (Figure
5).
In the second method, ADSCs were cultured
and differentiated on a plate and then transferred
from the plate to HAM. In this way, ADSCs
completely adhered to the stromal side or surface
of HAM, but compared with the previous method,
their thickness was less. In the control group,
ADSCs showed more integration into HAM (Figure
6).
Regarding micromass culture, chondrogenic
micromass was not appropriately attached
to HAM, and necrotic cells were observed
at the center of the micromass; however,
in the peripheral portion, there were
differentiated cells with a round nucleus (Figure
7).
Figure 2. A) Heterogeneous cell population containing fibroblast-like cells (black arrows) that grew out from the margins of the
tissue fragment (white arrow) were seen 7 days after adipose tissue fragments were explanted. B) The tissue fragment was
removed at day 11 as the cells became confluent. Mag: ×400, scale bar: 100 𝜇m.
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D
Figure 3. Immunophenotypic profile of adipose-derived stem cells (ADSCs). The mesenchymal stem cell (MSC) markers CD105
(A) and CD90 (B) were positive for ADSCs, whereas the hematopoietic MSC markers CD45 (C) and CD31 (D) were negative.
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Figure 4. Adipose-derived stem cells did not adhere to the epithelial side (A), but they attached and integrated into the stromal
layer of human amniotic membrane (B) (hematoxylin and eosin staining; Mag: ×10, scale bar: 100 𝜇m).
Figure 5. Culturing and differentiating adipose-derived stem cells on human amniotic membrane. (A) Control group, (B)
differentiation group, and (C) selected area under high magnification (hematoxylin and eosin staining. A and B, Mag: ×100 and C,
Mag: ×400; scale bar: 100 𝜇m).
Figure 6.Culturing chondrogenic differentiated cells on human amniotic membrane. (A) Control group and (B) differentiation group
(hematoxylin and eosin staining. Mag: ×400, scale bar: 100 𝜇m).
Figure 7. Micromass culture. (A) Low magnification and (B) high magnification of selected area. White arrows indicate necrotic
cells, yellow arrows indicate differentiated cells (hematoxylin and eosin staining. Mag: A, ×100 and B, ×400; scale bar: 100 𝜇m).
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4. Discussion
In this study, we cultured and differentiated
ADSCs using HAM as a scaffold by three
methods. We showed that ADSCs express MSC
markers and that HAM is a suitable scaffold for
cultivation and ADSC differentiation. We also
demonstrated that the stromal side of HAM
is more appropriate than the epithelial side
and that scaffold-mediated differentiation is
better than monolayer method and micromass
culture. Moreover, the differentiation of ADSCs
directly on HAM is more appropriate than the
transfer of chondrogenic differentiated cells to
HAM.
The ease of isolation and culture, high ability
to differentiate into other Cell types, and high
proliferation capacity make ADSCs a favorable
source of stem cells for tissue engineering
and cell therapy (11). These cells do not have
the disadvantages of chondrocytes including
restricted sources, high allograft rejection, and
phenotype loss (17). Although many previous
studies have reported that ADSCs have
appropriate chondrogenic differentiation potential
(9, 10), some studies have shown that using
bone marrow stromal cells for chondrogenesis
is better than using ADSCs (11). In this study,
ADSCs were isolated from human adipose
tissue and were cultured using HAM as a
scaffold for cartilage tissue engineering. Our
results indicate that the stromal side of HAM
has special features and could function as a
suitable biomaterial scaffold for culture and
chondrogenic differentiation of ADSCs. We
identified ADSCs based on morphology, plastic-
adhesion ability, and surface markers according
to the International Mesenchymal and Tissue
Stem Cell Committee announcement in 2006 (18).
Fourth-passaged ADSCs were spindle shaped
and were positive for CD105 and CD90 but were
negative for CD45 and CD31, similar to the findings
reported by De Francesco et al and Dominici et al
(19).
There are certain limitations to the use of cell
suspension in cell therapy for cartilage defect.
Methods that localize cells to the site of cartilage
lesions are less invasive and more attractive for
clinical use (20). By intra-articular injection of MSCs,
cells adhere to the synovial membrane, and only
a small amount of these cells are observed at
the site of cartilage defect. By further injection,
more cells attach to this site, but the number of
cells that adhere to the synovial membrane also
increases, thereby increasing the risk of synovial
proliferation (21). Therefore, the use of scaffolds
for cell delivery to the lesion site would be more
appropriate.
HAM is a fetal membrane that was first used
by Davis for skin transplantation in 1910 (22).
HAM has many advantages that make it a
suitable scaffold in tissue engineering such as
antimicrobial, antifibrosis, antiscarring, and anti-
inflammatory capacities as well as sufficient
mechanical properties (23, 24). HAM adheres
to the lesion site effortlessly, promotes wound
healing, reduces pain, and has low immunogenicity
(25). Additionally, it is inexpensive and a waste
biomaterial that can be easily processed,
cryopreserved, and de-epithelialized (23). Cell
adhesion to a scaffold mainly depends on ECM
components of the scaffold. HAM comprises
epithelium, basement membrane, and an avascular
stromal layer (26). Among these, the basement
membrane is one of the thickest membranes
found in human tissues and is composed of
collagen (types III and IV), laminin, fibronectin, and
other proteoglycans that are important for cell
adhesion and growth. In the avascular stromal
layer, collagen types I and III are abundant
and have a significant role in maintaining the
mechanical properties of the HAM. as well as,
in the stromal layer, there is perlecan that is
involved maintain the mechanical properties of
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HAM as well as perlecan that is involved in the
binding of growth factors and interaction with
ECM and cell adhesion molecules (24, 27). In
a previous study, we showed that HAM could
be a suitable scaffold for culturing fibroblasts,
and we provided an acceptable impermanent
skin substitute for skin wounds (12). In the
present study, we demonstrated that ADSCs
can be effectively cultured and differentiated
on HAM while remaining viable; thus, HAM
could be used as a suitable scaffold in cell
transplantation. Its stromal and epithelial layers
have different characteristics. Diaz-prado et al
cultured human chondrocytes on HAM and
reported that these cells grow on the stromal
layer better than on the epithelial layer (27).
In another study, chondrocytes were cultured
on the epithelial layer of intact HAM, epithelial
layer of denuded HAM, and stromal layer of
denuded HAM. The results showed better
growth and penetration of chondrocytes into
the stromal layer of denuded HAM and increased
expression of collagen type II in this group (16).
Chen et al (2012) also revealed that culturing
and osteogenic differentiation of human dental
apical papilla cells on the stromal layer of HAM
is more appropriate that those on the epithelial
layer (28). However, Yang et al indicated that
human keratinocytes adhere and grow better
on the epithelial layer of denuded HAM, with
fibroblasts being seeded on the stromal layer (29).
We showed that cultivation and differentiation of
ADSCs on the stromal layer of HAM were more
appropriate than those on the epithelial layer.
ADSCs properly adhered to the stromal layer
and integrate into it as well as had a suitable
thickness.
In this study, we showed that direct cell
differentiation on HAM is better than transferring
differentiated cells onto it. Nogami et al showed
that the rate of expression of collagen type II
increases in stem cells cultured on HAM. They
mentioned that HAM containing stem cells could
be a suitable scaffold for cartilage deficiency
(30).
In the three methods used for engineering
cartilage tissue, differentiation of ADSCs on the
stromal side of HAM showed better results.
Compared with scaffold-mediated differentiation,
micromass culture showed necrotic cells at the
center of micromass; furthermore, the micromass
could not attach to both sides of HAM. We
previously showed that micromass culture is
better than monolayer method for chondrogenic
differentiation of ADSCs (31). HAM could be
used as a suitable scaffold for cultivation and
differentiation of ADSCs without the presence of
necrotic cells and can be applied to articular
cartilage restoration.
Limitation
One of the limitations of this study is the lack
of evaluation of collagen type II and aggrecan with
immunohistochemistry or RT-PCR.
5. Conclusion
In conclusion, ADSCs have excellent attachment,
proliferation, and differentiation capacity on the
stromal layer of HAM. Moreover, the direct culture
and differentiation of ADSCs on HAM is a more
suitable method than the culture of chondrogenic
differentiated cells on HAM, and the formermethod
can provide an acceptable engineered cartilage
tissue that can be used for cartilage regeneration.
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